Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22541469 | 0.77 | CYP2C19 (0.31) | — | |
| SCHEMBL20746309 | 0.76 | HTT (0.39) | HTTCA1CA2CA9 | |
| SCHEMBL14511691 | 0.75 | — | — | |
| SCHEMBL1023192 | 0.73 | CA1 (0.33) | CA1CA2CA9 | |
| SCHEMBL4732844 | 0.73 | CA1 (0.33) | CA1CA2CA9 | |
| SCHEMBL3268915 | 0.73 | HTT (0.33) | HTT | |
| Sevoflurane SCHEMBL61918 | 0.71 | CA1 (0.32) | CA1CA2CA9 | |
| SCHEMBL457384 | 0.71 | — | — | |
| SCHEMBL14438874 | 0.71 | HTT (0.32) | HTT | |
| SCHEMBL7156993 | 0.71 | MEN1 (0.48) | HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023168268-A1 | AZEOTROPE OR AZEOTROPE-LIKE COMPOSITIONS OF 1,1,1,3,3,3-HEXAFLUORO-2-(2,2,2-TRIFLUOROETHOXY)PROPANE AND APPLICATIONS THEREOF | HONEYWELL INTERNATIONAL INC. (US) | 2023-09-07 | — | — | WO | claimed |
| US-20220235255-A1 | FLUORINE SUBSTITUTED UNSYMMETRICAL ETHERS, AND COMPOSITIONS, METHODS AND USES INCLUDING SAME | HONEYWELL INTERNATIONAL INC. (US) | 2022-07-28 | — | — | US | claimed |
| US-20260128377-A1 | ELECTROLYTE WITH HIGH LIFSI CONCENTRATION | ARKEMA FRANCE (FR) | 2026-05-07 | — | — | US | disclosed |
| EP-4716967-A1 | ELECTROLYTE WITH HIGH LIFSI CONCENTRATION | ARKEMA France (FR) | 2026-04-01 | — | — | EP | disclosed |
| WO-2025046186-A1 | ELECTROLYTE WITH LOW SULPHAMATE ION CONTENT | ARKEMA FRANCE (FR) | 2025-03-06 | — | — | WO | disclosed |
| WO-2024241002-A1 | ELECTROLYTE WITH HIGH LIFSI CONCENTRATION | ARKEMA FRANCE (FR) | 2024-11-28 | — | — | WO | disclosed |
| WO-2024110725-A1 | ELECTROLYTE WITH HIGH LOCAL CONCENTRATION OF LIFSI | ARKEMA FRANCE (FR) | 2024-05-30 | — | — | WO | disclosed |
| WO-2023168268-A1 | AZEOTROPE OR AZEOTROPE-LIKE COMPOSITIONS OF 1,1,1,3,3,3-HEXAFLUORO-2-(2,2,2-TRIFLUOROETHOXY)PROPANE AND APPLICATIONS THEREOF | HONEYWELL INTERNATIONAL INC. (US) | 2023-09-07 | — | — | WO | disclosed |
| WO-2023168268-A1 | AZEOTROPE OR AZEOTROPE-LIKE COMPOSITIONS OF 1,1,1,3,3,3-HEXAFLUORO-2-(2,2,2-TRIFLUOROETHOXY)PROPANE AND APPLICATIONS THEREOF | HONEYWELL INTERNATIONAL INC. (US) | 2023-09-07 | — | — | WO | disclosed |
| WO-2023168268-A1 | AZEOTROPE OR AZEOTROPE-LIKE COMPOSITIONS OF 1,1,1,3,3,3-HEXAFLUORO-2-(2,2,2-TRIFLUOROETHOXY)PROPANE AND APPLICATIONS THEREOF | HONEYWELL INTERNATIONAL INC. (US) | 2023-09-07 | — | — | WO | disclosed |
| US-9751821-B1 | Method for production of 3-hydroxypropan-1-one compound, method for production of 2-propen-1-one compound and method for production of isoxazoline compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-09-05 | — | — | US | disclosed |
| US-7700808-B2 | 1-3-bis(substituted phenyl)-3-hydroxypropan-1-one or 2-propen-1-one compound, and salt thereof | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-04-20 | — | — | US | disclosed |
| EP-2172462-A1 | METHOD FOR PRODUCTION OF 3-HYDROXYPROPAN-1-ONE COMPOUND, METHOD FOR PRODUCTION OF 2-PROPEN-1-ONE COMPOUND, AND METHOD FOR PRODUCTION OF ISOXAZOLINE COMPOUND | Nissan Chemical Industries, Ltd. (JP) | 2010-04-07 | — | — | EP | disclosed |
| US-20090023923-A1 | 1,3-Bis(Substituted Phenyl)-3-Hydroxypropan-1-One or 2-Propen-1-One Compound, and Salt Thereof | NISSAN CHEMICAL INDUSTRIES, LTD (JP) | 2009-01-22 | — | — | US | disclosed |
| EP-1975149-A1 | 1,3-BIS(SUBSTITUTED PHENYL)-3-HYDROXYPROPAN-1-ONE OR 2-PROPEN-1-ONE COMPOUND, AND SALT THEREOF | Nissan Chemical Industries, Ltd. (JP) | 2008-10-01 | — | — | EP | disclosed |
| US-20070043011-A1 | Substituted benzanilide compound and noxious organism controlling agent | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2007-02-22 | — | — | US | disclosed |
| EP-1731512-A1 | ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND NOXIOUS ORGANISM CONTROL AGENT | Nissan Chemical Industries, Ltd. (JP) | 2006-12-13 | — | — | EP | disclosed |
| EP-1671941-A1 | SUBSTITUTED BENZANILIDE COMPOUND AND PEST CONTROL AGENT | Nissan Chemical Industries, Ltd. (JP) | 2006-06-21 | — | — | EP | disclosed |
| US-20050250822-A1 | Substituted benzanilide compound and noxious organism controlling agent | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2005-11-10 | — | — | US | disclosed |
| EP-1538138-A1 | SUBSTITUTED BENZANILIDE COMPOUND AND PEST CONTROL AGENT | NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) | 2005-06-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220235255-A1 | FLUORINE SUBSTITUTED UNSYMMETRICAL ETHERS, AND COMPOSITIONS, METHODS AND USES INCLUDING SAME | CBR1, AFF1, AFF2 | HTT 4044/4885CA1 1263/4885CA2 2041/4885 |
| US-20090023923-A1 | 1,3-Bis(Substituted Phenyl)-3-Hydroxypropan-1-One or 2-Propen-1-One Compound, and Salt Thereof | HCN1, CNPY2, CLIC1 | HTT 1873/4885CA1 1349/4885CA2 294/4885 |
| US-20070043011-A1 | Substituted benzanilide compound and noxious organism controlling agent | L3MBTL1, L3MBTL3, L3MBTL4 | HTT 3583/4885CA1 975/4885CA2 144/4885 |
| US-20050250822-A1 | Substituted benzanilide compound and noxious organism controlling agent | GCN1, L3MBTL3, L3MBTL4 | HTT 2820/4885CA1 1415/4885CA2 249/4885 |
| US-20260128377-A1 | ELECTROLYTE WITH HIGH LIFSI CONCENTRATION | CCNI, FLI1, FOS | HTT 3987/4885CA1 47/4885CA2 130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.